Get the Stockscreener App
10.58
1.59%
-0.12
Avadel Pharmaceuticals Plc stock is traded at $10.58, with a volume of 18,578.
It is down -1.59% in the last 24 hours and up +19.52% over the past month.
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
See More
Previous Close:
$10.70
Open:
$10.53
24h Volume:
18,578
Relative Volume:
0.01
Market Cap:
$1.02B
Revenue:
$47.56M
Net Income/Loss:
$-156.83M
P/E Ratio:
-5.7814
EPS:
-1.83
Net Cash Flow:
$-127.98M
1W Performance:
-4.53%
1M Performance:
+19.52%
6M Performance:
+33.29%
1Y Performance:
-36.22%
1-Day Range:
$10.44
$10.53
1-Week Range:
$10.48
$11.10
52-Week Range:
$6.38
$17.30
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
Name
Avadel Pharmaceuticals Plc
Sector
Phone
636-449-1830
Address
BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK, DUBLIN
Compare AVDL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVDL
Avadel Pharmaceuticals Plc
|
10.50 | 1.04B | 47.56M | -156.83M | -127.98M | -1.83 |
|
ZTS
Zoetis Inc
|
145.51 | 66.25B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.13 | 42.95B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.70 | 43.30B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.28 | 19.30B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
125.84 | 13.53B | 2.41B | 305.80M | 492.20M | 2.95 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-18-25 | Resumed | H.C. Wainwright | Buy |
| Feb-11-25 | Initiated | Deutsche Bank | Buy |
| Jun-12-24 | Initiated | Rodman & Renshaw | Buy |
| Mar-05-24 | Reiterated | H.C. Wainwright | Buy |
| Mar-05-24 | Reiterated | Needham | Buy |
| Mar-05-24 | Reiterated | Oppenheimer | Outperform |
| Feb-06-24 | Initiated | UBS | Buy |
| Nov-30-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-10-22 | Downgrade | Jefferies | Buy → Hold |
| Jul-28-22 | Resumed | Craig Hallum | Buy |
| May-26-22 | Downgrade | Stifel | Buy → Hold |
| Sep-23-21 | Initiated | Needham | Buy |
| Jul-31-20 | Initiated | Oppenheimer | Outperform |
| Jul-21-20 | Initiated | SVB Leerink | Outperform |
| Jun-30-20 | Initiated | H.C. Wainwright | Buy |
| Apr-03-20 | Initiated | Jefferies | Buy |
| Mar-12-20 | Initiated | Stifel | Buy |
| Feb-26-20 | Initiated | Piper Sandler | Overweight |
| Jan-30-20 | Initiated | Craig Hallum | Buy |
| Jun-14-19 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Feb-08-19 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
View All
Avadel Pharmaceuticals Plc Stock (AVDL) Latest News
Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter 2025 Financial Results on August 7 - The Manila Times
How Avadel Pharmaceuticals plc stock performs during market volatilityEntry Alert Based on Volume Spikes Detected - beatles.ru
Visualizing Avadel Pharmaceuticals plc stock with heatmapsCommunity Strategy With High Win Rate Backtested - metal.it
What institutional investors are buying Avadel Pharmaceuticals plc stockStock Market Review That Work - jammulinksnews.com
What makes Avadel Pharmaceuticals plc stock attractive to long term investorsFree Swing Trading Entry Point Signals - Newser
Can Avadel Pharmaceuticals plc recover in the next quarterAI Trading Suggestions With Accuracy Focus Released - metal.it
What MACD signals say about Avadel Pharmaceuticals plcEarly Entry Planner for Swing Candidates - Newser
What makes Avadel Pharmaceuticals plc stock price move sharplyEquity Market Return Forecast Model Update - Newser
Is Avadel Pharmaceuticals plc Stock a Smart Buy in 2025 Investment Analysis InsideEntry and Exit Strategy Optimizer Tool Tested - metal.it
Published on: 2025-07-30 11:28:28 - metal.it
Bullish Divergence Spotted in Avadel Pharmaceuticals plc MomentumMarket Momentum and Signal Alerts Suggest Reversal - metal.it
Combining price and volume data for Avadel Pharmaceuticals plcAI Entry Timing Prediction for Swing Traders - Newser
How to forecast Avadel Pharmaceuticals plc trends using time seriesSmart Money Tracking Signal Generator Activated - metal.it
Avadel Pharmaceuticals Elects New Board and Auditor - TipRanks
Heatmap Data Shows High Activity in Avadel Pharmaceuticals plc SectorRisk Managed Intraday Trade Alerts Increase in Volume - metal.it
Avadel Pharmaceuticals plc Shows Risk Reward Favoring UpsideQuick Gain Stock Watch With Indicators Reviewed - metal.it
Sector ETF Data Correlates with Strength in Avadel Pharmaceuticals plcHigh Win Rate Trading Opportunities Detected - metal.it
Is Avadel Pharmaceuticals plc showing signs of accumulationFree Reliable Chart-Based Trade Entries - Newser
When is Avadel Pharmaceuticals plc stock expected to show significant growthWealth Building Target Finder For Every Investor - jammulinksnews.com
Regression Model Predicts Rangebound Movement in Avadel Pharmaceuticals plcEarnings Play Trade Plan With Alerts Shared - metal.it
What is the risk reward ratio of investing in Avadel Pharmaceuticals plc stockUnlock powerful trading tools for investors - jammulinksnews.com
Does Avadel Pharmaceuticals plc stock perform well during market downturnsOutstanding capital returns - jammulinksnews.com
How Efficient Is Avadel Pharmaceuticals plc at Controlling Operating CostsFree Short-Term Stock Picks - metal.it
What catalysts could drive Avadel Pharmaceuticals plc stock higher in 2025Free Stock Market Mentorship - jammulinksnews.com
How many analysts rate Avadel Pharmaceuticals plc as a “Buy”Accelerated earnings growth - jammulinksnews.com
What is Avadel Pharmaceuticals plc company’s growth strategyOutstanding stock performance - jammulinksnews.com
What are the latest earnings results for Avadel Pharmaceuticals plcGet high-impact stock recommendations now - jammulinksnews.com
Avadel Pharmaceuticals PLC. (NASDAQ:AVDL) Shares Sold by New York State Common Retirement Fund - Defense World
What analysts say about Avadel Pharmaceuticals plc stockPhenomenal capital appreciation - PrintWeekIndia
What drives Avadel Pharmaceuticals plc stock priceJaw-dropping returns - Autocar Professional
Idiopathic Hypersomnia Treatment Market Propelled by Rising - openPR.com
Is Avadel Pharmaceuticals plc stock overhyped or has real potentialRapidly expanding wealth - jammulinksnews.com
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛
Is Avadel Pharmaceuticals plc a good long term investmentExceptional earning trajectories - Autocar Professional
Avadel Pharmaceuticals plc Stock Analysis and ForecastOverwhelming profit margins - jammulinksnews.com
Insider Stock Buying Reaches US$761.7k On Avadel Pharmaceuticals - simplywall.st
Avadel Pharmaceuticals Plc (NASDAQ:AVDL) Has Found A Path To Profitability - 富途牛牛
Avadel Pharmaceuticals (NASDAQ:AVDL) Now Covered by HC Wainwright - MarketBeat
Avadel Pharmaceuticals Plc Stock (AVDL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
0.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):